Case Report: Serplulimab-induced thyroid dysfunction in a patient with advanced small cell lung cancer
Studies have shown that the application of immune checkpoint inhibitors (ICIs) in solid tumors can easily affect the endocrine system, causing disorders of thyroid function, which are usually reversible after treatment cessation in most patients. Serplulimab is a PD-1 inhibitor and is used for treat...
Na minha lista:
| Principais autores: | , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Frontiers Media S.A.
2025-11-01
|
| coleção: | Frontiers in Oncology |
| Assuntos: | |
| Acesso em linha: | https://www.frontiersin.org/articles/10.3389/fonc.2025.1611425/full |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|